Autonomic Tech Announces Expanded Indication In Europe (CE Mark) For Disabling Migraine With Pulsante SPG Microstimulator System Post author:Sam Post published:March 9, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Tiny Bicycle Therapeutics Wrangles a $424 Million R&D Pact With Biogen Spinoff Bioverativ September 5, 2017 NightstaRx Appoints As Chief Development Officer August 1, 2017 BioLineRx To Report Annual 2016 Results On March 23, 2017 March 15, 2017
Tiny Bicycle Therapeutics Wrangles a $424 Million R&D Pact With Biogen Spinoff Bioverativ September 5, 2017